Maintenance of amphetamine induced stereotypy and locomotion requires ongoing dopamine receptor activation

Psychopharmacology

Volumn 130, Issue 2, 1997, Pages 183-188

  Conti, Lisa H ^a   Segal, David S ^a   Kuczenski, Ronald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Dopamine; Dopamine antagonist; Haloperidol; Locomotion; Stereotypy

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; STEREOTYPED BEHAVIOR;

EID: 0030969325     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050227     Document Type: Article

References (28)

1. Arnt J, Christensen AV (1981) Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. Eur J Pharmacol 69:107-111
2. Barnett JV, Kuczenski R (1986) Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. J Pharmacol Exp Ther 237:820-825
3. Del Rio J, Fuentes JA (1969) Further studies on the antagonism of stereotyped behavior induced by amphetamine. Eur J Pharmacol 8:73-78
4. Devoto P, De Mentis G, Tagliamonte A (1992) Failure by tricyclic antidepressants to affect the increase of dopamine extracellular concentrations produced by haloperidol in the caudate and accumbens nuclei of rats. Biochem Pharmacol 43:507-511
5. Kuezenski R, Leith NJ (1981) Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance or reverse tolerance? Pharmacol Biochem Behav 15:405-413
6. Kuczenski R, Segal DS (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065
7. Kuczenski R, Segal DS (1990) In vivo measures of monoamines during amphetamine-induced behaviors in rats. Prog Neuropsychopharmacol Biol Psychiatry 14:S37-S50
8. Kuczenski R, Segal DS (1992) Regional norepinephrine response to amphetamine using dialysis: comparison to caudate dopamine. Synapse 11:164-169
9. Kuczenski R, Segal DS (1994) Neurochemistry of amphetamine. In: Cho AK, Segal DS (eds) Amphetamine and its analogs. Academic Press, San Diego, pp 81-113
10. Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703-2712
11. Kuczenski R, Segal DS, Cho AK, Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin. and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317
12. Lang A, Soosaar A, Koks S, Volke V, Bourin M, Bradwejn J, Vasar E (1994) Pharmacological comparison of antipsychotic drugs and σ-antagonists in rodents. Pharmacol Toxicol 75:222-227
13. Lynch MR, Kuhn HG, Carey RJ (1988) Chronic haloperidolamphetamine interactions and mesolimbic dopamine. Neuropsychobiology 19:97-103
14. Megens AAHP, Awouters FHL, Niemegeers CJE (1989) Interaction of haloperidol and risperidone (R 64 766) with amphetamine-induced motility changes in rats. Drug Dev Res 17:23-33
15. Megens AAHP, Niemegeers CJE, Awouters FHL (1992) Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol. J Pharmacol Exp Ther 260: 160-167
16. Mueller K (1993) Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine. Pharmacol Biochem Behav 45:71-76
17. Porras A, Mora F (1993) Dopamine receptor antagonists blocks the release of glycine, GABA, and taurine produced by amphetamine. Brain Res Bull 31:305-310
18. Rebec GV, Centore JM, White LK, Alloway KD (1985) Ascorbicacid and the behavioral response to haloperidol: implications lor the action of antipsychotic drugs. Science 227:438-440
19. 1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments. J Neurosci 6:2245-2251
20. 1 site. Mol Pharmacol 34:148-156
21. Schulz DW, Staples L, Mailman RB (1985) SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors. Life Sci 36:1941-1948
22. Segal DS (1975) Behavioral and neurochemical correlates of repeated d-amphetamine administration. In: Mandell AJ (ed) Neurobiological mechanisms of adaptation and behavior. Raven Press, New York, pp 247-262
23. Segal DS, Kuczenski R (1987) Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J Pharmacol Exp Ther 242:917-926
24. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on eatecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639-677
25. Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U (1987) A direct comparison of amphetamine-induced behaviors and regional dopamine release in the rat using intracerebral dialysis. Brain Res 401:322-330
26. Tschanz JT, Rebec GV (1989) Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacol Biochem Behav 31:519-522
27. Turski L, Schwarz M, Sontag KH (1984) Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction? Behav Brain Res 12:29-37
28. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469 492